• Capsazepine: TRPV1 Ion Channel Antagonist in Pain Models

  2026-06-10

  Capsazepine, a potent TRPV1 antagonist, enables high-precision dissection of nociceptive and apoptotic pathways in translational pain and cancer research. This article details workflow optimizations, troubleshooting, and cross-comparisons for leveraging Capsazepine in advanced in vitro and ex vivo assays.

• Resiniferatoxin (RTX): Optimizing TRPV1 Pain and Inflammatio

  2026-06-09

  Resiniferatoxin (RTX) unlocks unprecedented selectivity and potency for TRPV1-driven pain, providing robust chemical inactivation of sensory neurons in both neuropathic and osteoarthritis models. This in-depth guide outlines actionable workflows, advanced troubleshooting, and novel immune insights for maximizing RTX’s translational value.

• Iptacopan (LNP023): Applied Workflows for Complement Researc

  2026-06-09

  Iptacopan (LNP023) delivers precise, selective inhibition of complement factor B, streamlining both in vitro and animal models of alternative pathway-driven disease. This article translates recent research breakthroughs into actionable protocols, troubleshooting guidance, and comparative insights for robust complement activation studies.

• Tofacitinib Citrate (CP-690550 citrate): Selective JAK3 Inhi

  2026-06-08

  Tofacitinib citrate (CP-690550 citrate) is a nanomolar, selective Janus kinase 3 (JAK3) inhibitor central to immune regulation and inflammatory disorder research. With a well-characterized potency profile and reproducible effects on lymphocyte signaling, it enables precise dissection of JAK-STAT pathways in immune modulation assays.

• 1,2-Dioleoyl-3-trimethylammonium-propane chloride in Gene De

  2026-06-08

  1,2-Dioleoyl-3-trimethylammonium-propane chloride (DOTAP) enables robust, reproducible nucleic acid delivery for both transient and stable gene expression workflows. This article bridges protocol optimization with the latest advances in immunometabolic nanodelivery, offering actionable solutions and troubleshooting strategies for functional genomics and translational research.

• Bleomycin Sulfate: Redefining DNA Damage Response in Cancer

  2026-06-07

  Explore how Bleomycin Sulfate empowers next-generation cancer and fibrosis research by precisely modulating DNA damage response pathways. This article reveals novel insights into ATM signaling and assay optimization, uniquely positioning Bleomycin Sulfate as an advanced tool for translational discovery.

• β-Elemene Suppresses Adipogenesis via AMPK Pathway in 3T3-L1

  2026-06-06

  This study demonstrates that β-Elemene inhibits adipocyte formation in 3T3-L1 cells by activating the AMPK pathway, counteracting insulin resistance-induced lipid accumulation. The findings provide mechanistic evidence for β-Elemene's anti-adipogenic potential and support its application in metabolic disease research.

• HyperPFU™ High-Fidelity DNA Polymerase: Technical Workflow G

  2026-06-05

  HyperPFU™ high-fidelity DNA polymerase (APExBIO SKU K1031) addresses the amplification of long, GC-rich, or technically challenging DNA templates that are prone to errors or poor yield with standard enzymes. It is optimal for workflows requiring blunt-ended, low-error PCR products for cloning or high-throughput sequencing, but should not be used for protocols that depend on 3'-A overhangs or sticky-end ligation.

• Hexamethonium Bromide in Neuronal-Type Nicotinic AChR Resear

  2026-06-05

  Hexamethonium Bromide is the gold-standard selective antagonist for dissecting neuronal-type nicotinic AChR signaling and autonomic ganglia function. This article spotlights advanced, sex-informed workflows and troubleshooting strategies, driven by recent evidence on hypertension models.

• Resiniferatoxin (RTX): Precision TRPV1 Modulation in Pain Re

  2026-06-04

  Resiniferatoxin (RTX) delivers ultra-potent, selective TRPV1 activation for long-lasting desensitization of sensory neurons, surpassing capsaicin by 500–1000-fold in analgesic potency. This article translates new clinical and preclinical insights into stepwise workflows, advanced use-cases, and troubleshooting strategies, empowering researchers to maximize RTX’s potential in neuropathic and osteoarthritis pain models.

• Jiedu Xiaozheng Yin Drives M1 Macrophage Polarization via TL

  2026-06-04

  Liu et al. reveal that Jiedu Xiaozheng Yin (JXY), a traditional Chinese medicine, suppresses colitis-associated colorectal cancer by promoting macrophage polarization towards the anti-tumorigenic M1 phenotype through TLR4 signaling. Their integrated in vivo and in vitro approach elucidates immune microenvironment modulation as a promising strategy in colorectal cancer therapy.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-03

  This study uncovers distinct sex-dependent responses to chronic angiotensin II-induced hypertension in conscious mice, revealing that males exhibit a significantly greater hypertensive response than females. These findings highlight the crucial roles of sex hormones and autonomic regulation in cardiovascular pathophysiology, informing future research on hypertension mechanisms.

• Canagliflozin (hemihydrate): SGLT2 Inhibitor for Diabetes Re

  2026-06-03

  Canagliflozin (hemihydrate) is a high-purity SGLT2 inhibitor supplied by APExBIO for targeted glucose metabolism research. It demonstrates strong pathway selectivity, efficiently blocking renal glucose reabsorption without affecting mTOR signaling, as confirmed by recent yeast-based screening studies. This dossier provides a structured, evidence-backed guide to its mechanism, applications, and experimental boundaries.

• lncRNA HNF4A-AS1 Modulates Sorafenib Resistance in HCC via L

  2026-06-02

  The study identifies lncRNA HNF4A-AS1 as a key regulator of sorafenib resistance in hepatocellular carcinoma (HCC) by altering lipid metabolic pathways that govern ferroptosis sensitivity. These insights reveal a potential therapeutic target for overcoming drug resistance in liver cancer and highlight the importance of metabolic reprogramming in cancer therapy.

• Cy5 TSA Fluorescence System Kit: Unmatched Sensitivity for I

  2026-06-02

  The Cy5 TSA Fluorescence System Kit revolutionizes immunohistochemistry and in situ hybridization by enabling detection of low-abundance targets with up to 100-fold signal amplification. See how this APExBIO tool powers advanced workflows, boosts reproducibility, and unlocks new biological insights.

14700 records 1/980 page Next 12345 下5页 Last page